Agents for the treatment of rheumatic diseases

Irena Zimmermann-Górska

ISSN: 1505-8409

Przewodnik Lekarza/Guide for GPs

Current issue Archive About the journal Supplements Contact Instructions for authors

3/2007
vol. 10

Send email

Copy url:

abstract:

Agents for the treatment of rheumatic diseases

Irena Zimmermann-Górska

Przew Lek 2007; 3: 40-47

Online publish date: 2007/05/11

View full text Get citation

Characteristics of the TNF-α blocking agents (infliximab, etanercept, adalimumab), IL-1 blocking agent (anakinra), costimulatory blocking agent (abatacept) and anti-CD20 monoclonal antibody (rituximab), their efficacy in the most frequent inflammatory rheumatic diseases, their toxicity as well as the emerging biological therapies, are presented.

keywords:

Agents for the treatment of rheumatic diseases

Irena Zimmermann-Górska

choroby reumatyczne, leki biologiczne